Curcumin Compositions for Specialized Applications
Legal Citation
Summary of the Inventive Concept
Adaptations of curcumin compositions for specific, narrow markets or unique operational environments, such as disaster relief, high-security needs, and extreme weather conditions.
Background and Problem Solved
The original patent disclosed curcumin compositions as NK3 antagonists, but the inventors recognized the need for specialized variations to address unique challenges in various environments. The new inventive concept addresses these limitations by providing tailored formulations and delivery systems for high-stress, resource-constrained, or extreme weather situations.
Detailed Description of the Inventive Concept
The new claims introduce curcumin compositions formulated for rapid deployment in extreme weather conditions, covert administration in high-security zones, and emergency response situations. These compositions feature optimized ratios of diferuloylmethane to DMC, tetrahydrocurcumin to dihydrocurcumin, hexahydrocurcumin to octahydrocurcumin, and other curcuminoids. The inventive concept also encompasses novel packaging and delivery systems, such as portable, waterproof containers and water purification systems, to ensure the compositions remain effective in challenging environments.
Novelty and Inventive Step
The new claims introduce a novel combination of curcuminoids and formulations tailored to specific, high-stress environments, which is not anticipated by the original patent. The inventive concept's focus on specialized applications and unique operational environments constitutes a non-obvious advancement over the prior art.
Alternative Embodiments and Variations
Other embodiments of the inventive concept could include curcumin compositions for use in space exploration, search and rescue operations, or remote medical treatment in areas with limited access to medical resources. Variations may also include different ratios of curcuminoids, alternative delivery systems, or additional components to enhance the compositions' efficacy and stability.
Potential Commercial Applications and Market
The inventive concept has significant commercial potential in various industries, including disaster relief, emergency response, and high-security medical services. The target market includes government agencies, non-governmental organizations, and private companies operating in high-stress environments.
CPC Classifications
| Section | Class | Group |
|---|---|---|
| A | A61 | A61K36/9066 |
| A | A61 | A61K31/26 |
| A | A61 | A61K36/82 |
| A | A61 | A61P15/12 |
Section 103 Obviousness Analysis (PHOSITA)
Field of Art
Pharmaceutical compositions, specifically natural product-based therapeutic formulations with a focus on curcuminoid compounds and their medical applications, requiring advanced knowledge of organic chemistry, pharmacology, and natural product extraction techniques
Person of Ordinary Skill (PHOSITA) Profile
A researcher or pharmaceutical formulation specialist with advanced degrees in chemistry or pharmacology, experienced in natural product extraction, compound modification, and therapeutic composition design, familiar with curcuminoid structural variations and medical applications
Obviousness Rationale
A PHOSITA would recognize that the source patent's foundational work on curcumin compositions provides a clear framework for exploring derivative formulations targeting specialized environments. The PTD's variations represent predictable extensions of known curcuminoid modification techniques, utilizing standard pharmaceutical engineering approaches to adapt the base composition for specific operational contexts. The disclosed ratios and formulation strategies demonstrate incremental modifications that would be readily conceived by a skilled practitioner familiar with natural product composition design.
Obvious Combinations & Variations
Original Patent Information
| Patent Number | US 11,857,594 |
|---|---|
| Title | Curcumin compositions and methods of use as an NK3 antagonist |
| Assignee(s) | JDS Therapeutics, LLC |